Search results
Yingli Ma, Ph.D. Chief Technology Officer. Dr. Ma has more than 15 years of research, technology and drug discovery experience in pharma and biotech settings. Prior to joining Structure, Dr. Ma was site head and General Manager of Amgen Biopharmaceutical R&D (Shanghai), responsible for Amgen’s structural biology and China research platforms, ...
Yingli Ma. Yingli Ma, born in 1965, is from an ordinary Chinese family, whose everyday life provides insight into China’s changing society. She studied film at the German Film and Television School in Berlin, Germany (DFFB).
Ma Yingli is Chief Technology Officer at Structure Therapeutics Inc. See Ma Yingli's compensation, career history, education, & memberships.
Chief Technology Officer at Structure Therapeutics. Show contact. Yingli Ma has a diverse work experience spanning various roles in the pharmaceutical and biotechnology industry. They started their career at Rockefeller University as a Postdoctoral Associate from August 2005 to March 2009.
General Manager & President, ShouTi Basecamp Bio. Current role. Dr. Ma has more than 15 years of research, technology, and drug discovery experience in pharma and biotech settings. Prior to joining ShouTi, Dr.
In Brief. Ma et al. present an atomic-resolution structure of the human apelin receptor (APJR, a class A G-protein-coupled receptor) in complex with a 17-residue apelin peptide mimic by X-ray crystallography. This structure reveals a two-site ligand binding mode that has not been seen in any other solved class A receptor structures. Structure.
Yingli Ma is currently Chief Technology Officer at Structure Therapeutics. At Structure Therapeutics, Yingli Ma has 18 colleagues including Raymond Stevens (CEO), Joanne Waldstreicher (Director)…
